Breast Cancer Clinical Trial
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
Summary
Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
55-70 years of age, Post menopausal
Exclusion Criteria:
If they have ever used hormone replacment therapy or have ever used Tamoxifen or Raloxifene, Diag. with breast cancer have had breast implants or have had a mastectomy/
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
University of Wisconsin Hospital
Madison Wisconsin, 53792, United States
Madison Wisconsin, 53792, United States
How clear is this clinincal trial information?